Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Lowe's Companies
LOW
|
+$257M |
| 2 |
JPMorgan Chase
JPM
|
+$211M |
| 3 |
Intel
INTC
|
+$200M |
| 4 |
Home Depot
HD
|
+$183M |
| 5 |
TECD
Tech Data Corp
TECD
|
+$182M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
+$685M |
| 2 |
Meta Platforms (Facebook)
META
|
+$132M |
| 3 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$129M |
| 4 |
NVIDIA
NVDA
|
+$127M |
| 5 |
Merck
MRK
|
+$108M |
Sector Composition
| 1 | Healthcare | 14.98% |
| 2 | Technology | 13.18% |
| 3 | Financials | 12.05% |
| 4 | Consumer Discretionary | 11.76% |
| 5 | Industrials | 10.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Brink's
BCO
$4.83B
| $3.74M | 0.01% |
82,134
-5,628
| -6% | -$256K |
|
1577
Viasat
VSAT
$4.1B
| $3.74M | 0.01% |
97,415
+75,947
| +354% | +$2.91M |
|
1578
Allete
ALE
$3.67B
| $3.73M | 0.01% |
68,344
+51,484
| +305% | +$2.81M |
|
1579
Accenture
ACN
$149B
| $3.72M | 0.01% |
17,305
-113,870
| -87% | -$24.5M |
|
1580
UBS Group
UBS
$129B
| $3.7M | 0.01% |
320,954
+219,336
| +216% | +$2.53M |
|
1581
iShares Russell 1000 ETF
IWB
$44.5B
| $3.7M | 0.01% |
+21,568
| New | +$3.7M |
|
1582
Kemper
KMPR
$3.35B
| $3.7M | 0.01% |
50,989
-50,565
| -50% | -$3.67M |
|
|
KIN
1583
DELISTED
Kindred Biosciences, Inc.
KIN
| $3.69M | 0.01% |
+821,752
| New | +$3.69M |
|
1584
Hormel Foods
HRL
$13.8B
| $3.68M | 0.01% |
+76,282
| New | +$3.68M |
|
|
NBSE
1585
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $3.68M | 0.01% |
20,966
+19,794
| +1,689% | +$3.48M |
|
1586
Robert Half
RHI
$3.61B
| $3.68M | 0.01% |
69,684
+27,550
| +65% | +$1.46M |
|
1587
Wolfspeed
WOLF
$365M
| $3.68M | 0.01% |
+62,154
| New | +$3.68M |
|
|
AIMT
1588
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $3.68M | 0.01% |
220,159
-211,082
| -49% | -$3.53M |
|
|
FUSN
1589
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $3.68M | 0.01% |
+210,501
| New | +$3.68M |
|
|
OYST
1590
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $3.68M | 0.01% |
127,310
+120,898
| +1,885% | +$3.49M |
|
|
CBD
1591
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $3.68M | 0.01% |
281,246
-25,762
| -8% | -$337K |
|
|
AVTA
1592
DELISTED
Avantax, Inc. Common Stock
AVTA
| $3.66M | 0.01% |
320,530
+290,274
| +959% | +$3.31M |
|
1593
Zynex
ZYXI
$44.8M
| $3.66M | 0.01% |
+161,729
| New | +$3.66M |
|
1594
Primoris Services
PRIM
$6.59B
| $3.65M | 0.01% |
+205,656
| New | +$3.65M |
|
1595
Edgewell Personal Care
EPC
$1.01B
| $3.62M | 0.01% |
116,049
+63,276
| +120% | +$1.97M |
|
1596
H.B. Fuller
FUL
$3.33B
| $3.61M | ﹤0.01% |
80,868
-112,674
| -58% | -$5.03M |
|
1597
Monarch Casino & Resort
MCRI
$1.9B
| $3.6M | ﹤0.01% |
105,684
-199,631
| -65% | -$6.8M |
|
|
CPAAU
1598
DELISTED
Conyers Park II Acquisition Corp. Unit
CPAAU
| $3.6M | ﹤0.01% |
300,000
| – | – |
|
1599
Compugen
CGEN
$125M
| $3.59M | ﹤0.01% |
239,059
+106,609
| +80% | +$1.6M |
|
1600
AngioDynamics
ANGO
$433M
| $3.59M | ﹤0.01% |
+352,977
| New | +$3.59M |
|